Differential induction of protein kinase C isoforms at the cardiac hypertrophy stage and congestive heart failure stage in Dahl salt-sensitive rats

Hypertension Research

Volumn 26, Issue 5, 2003, Pages 421-426

  Koide, Yuichi ^a   Tamura, Kouichi ^a   Suzuki, Atsushi ^a   Kitamura, Kouichi ^a   Yokoyama, Keiko ^a   Hashimoto, Tatsuo ^a   Hirawa, Nobuhito ^a   Kihara, Minoru ^a   Ohno, Shigeo ^a   Umemura, Satoshi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Dahl salt sensitive rat; Heart failure; Hypertrophy; Protein kinase C (PKC); Signal transduction

Indexed keywords

ISOENZYME; ISOPROTEIN; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; PROTEIN KINASE C BETA1; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; UNCLASSIFIED DRUG;

ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOMEGALY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; ENZYMOLOGY; HEART MUSCLE; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HIGH SODIUM INTAKE; IMMUNOBLOTTING; MALE; METABOLISM; NONHUMAN; PHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RAT STRAIN; SIGNAL TRANSDUCTION; SODIUM RESTRICTION; STAGING; SYSTOLIC BLOOD PRESSURE; UPREGULATION;

ANIMALS; CARDIOMEGALY; HEART FAILURE, CONGESTIVE; ISOENZYMES; MALE; MYOCARDIUM; PROTEIN KINASE C; PROTEIN KINASE C-ALPHA; PROTEIN KINASE C-DELTA; PROTEIN KINASE C-EPSILON; RATS; RATS, INBRED DAHL; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 12444271164     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.26.421     Document Type: Article

References (49)

1. Yamazaki T, Yazaki Y: Molecular basis of cardiac hypertrophy. Z Kardiol 2000; 89: 1-6.
2. Zhang D, Gaussin V, Taffet GE, et al: TAK-1 activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice. Nat Med 2000; 6: 556-563.
3. Windt LJD, Lim HW, Haq S, et al: Calcineurin promotes protein kinase C and c-Jun NH2-terminal kinase activation in the heart cross-talk between cardiac hypertrophic signaling pathways. J Biol Chem 2000; 275: 13571-13579.
4. Hiroi Y, Hiroi J, Kudoh S, et al: Two distinct mechanisms of angiotensin II-induced negative regulation of the mitogen-activated protein kinases in cultured cardiac myocyte. Hypertens Res 2001; 24: 385-394.
5. Yamazaki T, Komuro I, Zou Y, et al: Hypertrophic responses of cardiomyocytes induced by endothlin-1 through the protein kinase C-dependent but Src and Ras-independent pathways. Hypertens Res 1999; 22: 113-119.
6. Sasamura H, Hein L, Saruta T, et al: Evidence for internalization of both type 1 angiotensin receptor subtypes (AT1a, AT1b) by protein kinase C independent mechanism. Hypertens Res 1997; 20: 295-300.
7. Nishizuka Y: Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 1992; 258: 607-614.
8. Newton A: Protein kinase C: structure, function, and regulation. J Biol Chem 1995; 270: 28496-28498.
9. Ohno S, Akita Y, Hata A, et al: Structural and functional diversities of a family of signal transducing protein kinases, protein kinase C family; two distinct classes of PKC, conventional cPKC and novel nPKC. Adv Enzyme Regul 1991; 31: 287-303.
10. Osada S, Mizuno K, Saido TC, et al: A new member of the protein kinase C family, nPKCθ, predominantly expressed in skeletal muscle. Mol Cell Biol 1992; 12: 3930-3938.
11. Akimoto K, Mizuno K, Osada S, et al: A new member of the third class in the protein kinase C family, PKCλ, expressed dominantly in undifferentiated mouse embryonal carcinoma cell line and also in many tissues and cells. J Biol Chem 1994; 269: 12677-12683.
12. Akimoto K, Takahashi R, Moriya S, et al: EGF or PDGF receptors activate atypical PKCλ through phosphastidylinositol 3-kinase. EMBO J 1996; 15: 788-798.
13. Akimoto K, Nakaya M, Yamanaka T, et al: Atypical protein kinase Cλ binds and regulates p70 S6 kinase. Biochem J 1998; 335: 417-424.
14. Naruse K, King GL: Protein kinase C and myocardial biology and function. Circ Res 2000; 86: 1104-1106.
15. 2+-sensitive isoforms in the failing human heart. Circulation 1999; 99: 384-391.
16. Chen L, Hahn H, Wu G, et al: Opposing cardioprotective actions and parallel hypertrophic effects of (δPKC and EPKC. Proc Natl Acad Sci USA 2001; 98: 11114-11119.
17. Takeishi Y, Jalili T, Ball NA, et al: Responses of cardiac protein kinase C isoforms to distinct pathological stimuli are differentially regulated. Circ Res 1999; 85: 264-271.
18. Qu P, Hamada M, Ikeda S, et al: Time-course changes in left ventricular geometry and function during the development of hypertension in Dahl salt-sensitive rats. Hypertens Res 2000; 23: 613-623.
19. Ohtsuka T, Suzuki M, Hamada K, et al: Cardiomyocyte functions couple with left ventricular geometric patterns in hypertension. Hypertens Res 2000; 23: 345-351.
20. Morii I, Kihara Y, Inoko M, et al: Myocardial contractile efficiency and oxygen cost of contractility are preserved during transition from compensated hypertrophy to failure in rats with salt-sensitive hypertension. Hypertension 1998; 31: 949-960.
21. Inagawa Y, Kihara Y, Hasegawa K, et al: Cardiac endothelin-1 plays a critical role in the functional deterioration of left ventricles during the transition from compensatory hypertrophy to congestive heart failure in salt-sensitive rats. Circulation 1998; 98: 2065-2073.
22. Kim S, Yoshiyama M, Izumi Y, et al: Effects of combination of ACE inhibitor and angiotensin receptor blocker on cardiac remodeling, cardiac function, and survival in rat heart failure. Circulation 2001; 103: 148-154.
23. Friedman M, Freed SC: Microphonic manometer for indirect determination of systemic blood pressure in rats. Proc Soc Exp Biol Med 1946; 70: 670-672.
24. 2+ channels in resistance arteries from Dahl salt-sensitive rats. Hypertens Res 2000; 23: 701-707.
25. Zhan Y, Kim S, Kawano H, et al: Enhancement of glomerular platelet-derived growth factor β-receptor tyrosine phosphorylation in hypertensive rats and its inhibition by calcium channel blocker. Hypertens Res 2002; 25: 295-301.
26. Iwata S, Tsujino T, Ikeda Y, et al: Decreased expression of arginase II in the kidneys of Dahl salt-sensitive rats. Hypertens Res 2002; 25: 411-418.
27. Kobayashi N, Nakano S, Mori Y, et al: Benedipine inhibits expression of ET-1 and TGF-β1 in Dahl salt sensitive rats. Hypertens Res 2001; 24: 241-250.
28. Kobayashi N, Nakano S, Mori Y, et al: Betaxolol inhibits extracellular signal-regulated kinase and p70S6 kinase activities and gene expressions of platelet-derived growth factor A-chain and transforming growth factor-β1 in Dahl salt-sensitive rats. Hypertens Res 2002; 25: 211-219.
29. Namba M, Kim S, Zhan Y, et al: Combination treatment with a calcium channel blocker and angiotensin blocker in a rat systolic heart failure model with hypertension. Hypertens Res 2002; 25: 461-466.
30. Rybin VO, Steinberg SF: Protein kinase C isoform expression and regulation in the developing rat heart. Circ Res 1994; 74: 299-309.
31. Rybin VO, Buttrick PM, Steinberg SF: PKC-λ is the atypical protein kinase C isoform, expressed by immature ventricle. Am J Physiol 1997; 269: H1636-H1642.
32. Paul K, Ball NA, Dorn II GW, et al: Left ventricular stretch stimulates angiotensin II-mediated phosphatidylinositol hydrolysis and protein kinase E isoform translocation in adult guinea pig hearts. Circ Res 1997; 81: 643-650.
33. Simpson PC: β-Protein kinase C and hypertrophic signaling in human heart failure. Circulation 1999; 99: 334-337.
34. Braz JC, Bueno OF, De Windt LJ, et al: PKCα regulates the hypertrophic growth of cardiomyocytes through extracellular signal-regulated kinase 1/2 (ERK1/2). J Cell Biol 2002; 156: 905-919.
35. Gu X, Bishop SP: Increased protein kinase C isozyme redistribution in pressure-overload cardiac hypertrophy in the rat. Circ Res 1994; 75: 926-931.
36. Fryer LGD, Holness MJ, Decock JBJ, et al: Cardiac protein kinase C expression in two models of cardiac hypertrophy associated with an activated cardiac renin-angiotensin system: effects of experimental hyperthyroidism and genetic hypertension (the mRen-2 rat). J Endocrinol 1998; 158: 27-33.
37. Gao PJ, Zhao GS, Yuan XY, et al: Expression of protein kinase C gene in the brain and heart of spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 1995; 1 (Suppl): S204-S206.
38. Rouet-Benzineb P, Mohammadi K, Perennec J, et al: Protein kinase C isoform expression in normal and failing rabbit hearts. Circ Res 1996; 79: 153-161.
39. 2+-dependent transgenic model of cardiac hypertrophy a role for protein kinase Cα. Circulation 2001; 103: 140-147.
40. Wakasaki H, Koya D, Schoen FJ, et al: Targeted overexpression of protein kinase C β2 isoform in myocardial causes cardiomyopathy. Proc Natl Acad Sci USA 1997; 94: 9320-9325.
41. Bowman JC, Steinberg SF, Jiang T, et al: Expression of protein kinase C β in the heart causes hypertrophy in adult mice and sudden death in neonates. J Clin Invest 1997; 100: 2189-2195.
42. Takeishi Y, Chu G, Kirkpatric D, et al: In vivo phosphorylation of cardiac troponin I by protein kinase β decreases cardiomyocyte calcium responsiveness and contractility in transgenic mouse heart. J Clin Invest 1998; 102: 72-78.
43. Dorn II GW, Souroujon MC, Liron T, et al: Sustained in vivo cardiac protection by a rationally designed peptide that causes E protein kinase C translocation. Proc Natl Acad Sci USA 1999; 96: 12798-12803.
44. Mochey-Rosen D, Wu G, Hahn H, et al: Cardiotrophic effects of protein kinase CE analysis by in vivo modulation of PKCE translocation. Circ Res 2000; 86: 1173-1179.
45. Takeishi Y, Ping P, Bolli R, et al: Transgenic overexpression of constitutively active protein kinase C E causes concentric cardiac hypertrophy. Circ Res 2000; 86: 1218-1223.
46. Inagaki K, Iwanaga Y, Sarai N, et al: Tissue angiotensin II during progression or ventricular hypertrophy to heart failure in hypertensive rats; differential effects on PKCE and PKCβ. J Mol Cell Cardiol 2002; 34: 1377-1385.
47. Roman BB, Geenen DL, Leitges M, et al: PKC-β is not necessary for cardiac hypertrophy. Am J Physiol Heart Circ Physiol 2001; 280: H2264-H2270.
48. Inagami K, Kihara Y, Hayashida W, et al: Anti-ischemic effect of novel cardioprotective agent JTV519, is mediated through specific activation of δ-isoform of protein kinase C in rat ventricular myocardium. Circulation 2000; 101: 797-804.
49. Shizukuda Y, Helisch A, Yokota R, et al: Down regulation of protein kinase Cδ activity enhances endothelial cell adaptation to hypoxia. Circulation 1999; 100: 1909-1916.